Role of pharmacist during COVID-19 pandemic: an updated review

Public health officials are concerned about COVID-19, which can cause severe acute respiratory illness in humans. Since its discovery in Wuhan, China, in December 2019, it has spread rapidly around the world. The causative virus, SARS-CoV-2, has been named Coronavirus Disease 2019 by the World Health Organization (WHO) (COVID-19). Italy was the first western country to be hit by the pandemic, and COVID-19 was found there. RT-PCR tests, therapy controversies, intrauterine transmission and maternal-fetal complications are some of the diagnostic issues that need to be addressed in order to understand pathogenesis and vulnerability. When it comes to medical conditions that require medication and equipment, such as protective clothing, pharmacists have been instrumental in helping patients learn about their options. Patients must be assured that pharmacists will be available to assist them at all times during the outbreak in order to ensure their safety. Medicine management services are provided by pharmacists in both hospital and outpatient clinics, as well as by long-term care facilities and doctor's offices, as well as by national and public health organizations. The need for ambulatory care clinical pharmacists has been highlighted at COVID-19, and their numbers are rising. The pandemic of COVID-19 could affect more than two-thirds of the world's population. Physical, social, emotional, spiritual and psychological well-being are all components of a person's health.